Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav Efficacy in Glaucoma/OHT Uncontrolled on Beta-blockers
NCT02003391Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Dec 2013
- Primary completion
- May 2015
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 4 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Dec 2013; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02003391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02003391.